These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26720709)

  • 21. Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes.
    Kolodziejski PA; Pruszynska-Oszmalek E; Sassek M; Kaczmarek P; Szczepankiewicz D; Billert M; Mackowiak P; Strowski MZ; Nowak KW
    J Diabetes; 2017 Apr; 9(4):353-361. PubMed ID: 27106635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Augmented insulinotropic action of arachidonic acid through the lipoxygenase pathway in the obese Zucker rat.
    Ahrén B; Magrum LJ; Havel PJ; Greene SF; Phinney SD; Johnson PR; Stern JS
    Obes Res; 2000 Sep; 8(6):475-80. PubMed ID: 11011915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat.
    Doshi LS; Brahma MK; Sayyed SG; Dixit AV; Chandak PG; Pamidiboina V; Motiwala HF; Sharma SD; Nemmani KV
    Metabolism; 2009 Mar; 58(3):333-43. PubMed ID: 19217448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A low protein diet lowers islet insulin secretion but does not alter hyperinsulinemia in obese Zucker (fa/fa) rats.
    Tse EO; Gregoire FM; Magrum LJ; Johnson PR; Stern JS
    J Nutr; 1995 Jul; 125(7):1923-9. PubMed ID: 7616309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.
    Bergeron R; Yao J; Woods JW; Zycband EI; Liu C; Li Z; Adams A; Berger JP; Zhang BB; Moller DE; Doebber TW
    Endocrinology; 2006 Sep; 147(9):4252-62. PubMed ID: 16728496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans.
    Poitout V; Rouault C; Guerre-Millo M; Briaud I; Reach G
    Endocrinology; 1998 Mar; 139(3):822-6. PubMed ID: 9492008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery and Characterization of Novel GPR39 Agonists Allosterically Modulated by Zinc.
    Sato S; Huang XP; Kroeze WK; Roth BL
    Mol Pharmacol; 2016 Dec; 90(6):726-737. PubMed ID: 27754899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of islet 5-HT4 receptor regulates glycemic control through promoting insulin secretion.
    Chen H; Hong F; Chen Y; Li J; Yao YS; Zhang Y; Zheng LF; Zhu JX
    Eur J Pharmacol; 2016 Oct; 789():354-361. PubMed ID: 27423314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of Zn2+ on glucose-induced electrical activity and insulin release from mouse pancreatic islets.
    Ferrer R; Soria B; Dawson CM; Atwater I; Rojas E
    Am J Physiol; 1984 May; 246(5 Pt 1):C520-7. PubMed ID: 6372518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose refractoriness of beta-cells from fed fa/fa rats is ameliorated by nonesterified fatty acids.
    Chan CB; Surette JJ
    Can J Physiol Pharmacol; 1999 Dec; 77(12):934-42. PubMed ID: 10606439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion.
    Yoshida S; Ohishi T; Matsui T; Shibasaki M
    Biochem Biophys Res Commun; 2010 Sep; 400(3):437-41. PubMed ID: 20804735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPR39, a receptor of the ghrelin receptor family, plays a role in the regulation of glucose homeostasis in a mouse model of early onset diet-induced obesity.
    Verhulst PJ; Lintermans A; Janssen S; Loeckx D; Himmelreich U; Buyse J; Tack J; Depoortere I
    J Neuroendocrinol; 2011 Jun; 23(6):490-500. PubMed ID: 21470317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Cell Inactivation of
    Panaro BL; Flock GB; Campbell JE; Beaudry JL; Cao X; Drucker DJ
    Diabetes; 2017 Jun; 66(6):1626-1635. PubMed ID: 28254842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced insulin secretion and calcium uptake by Zucker "fatty" rat islets.
    Pansini AR; Tolman EL
    Horm Metab Res; 1981 Aug; 13(8):430-3. PubMed ID: 7035321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diethyldithiocarbamate-mediated zinc ion chelation reveals role of Cav2.3 channels in glucagon secretion.
    Drobinskaya I; Neumaier F; Pereverzev A; Hescheler J; Schneider T
    Biochim Biophys Acta; 2015 May; 1853(5):953-64. PubMed ID: 25603538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean, but not obese, rats.
    Zawalich WS; Zawalich KC
    Endocrinology; 2000 Sep; 141(9):3287-95. PubMed ID: 10965900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DC260126, a small-molecule antagonist of GPR40, improves insulin tolerance but not glucose tolerance in obese Zucker rats.
    Zhang X; Yan G; Li Y; Zhu W; Wang H
    Biomed Pharmacother; 2010 Nov; 64(9):647-51. PubMed ID: 20888730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic treatment of JTP-109192, a novel G-protein coupled receptor 119 agonist, improves metabolic abnormalities in Zucker Fatty rats.
    Tadaki H; Sasase T; Fukuda S; Toriniwa Y; Harada K; Ohta T; Yamada T
    Clin Exp Pharmacol Physiol; 2019 Oct; 46(10):910-919. PubMed ID: 31380572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.